Epstein Secrets

solidify its position as a go-to medicine for Covid-19 patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries

The AR (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases Spike. ABC World News Tonight (10/22, story 4, 3:00, Muir, 6.71M) r

e market." USA Today <https://www.usatoday.com/story/news/health/2020/10/22/fda-approves-remdesivir-covid-19- hospital-patients/3733648001/> (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. The New York

d Bloomberg <https://www.bloomberg.corninews/articles/2020-10-22/yields-up-on-stimulus-hopes-asia-stocks-to-drift- markets-wrap?smd=premium> (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases Spike. ABC World News Tonight <https://playvideo.bulletinintelligence

solidify its position as a go-to medicine for Covid-19 patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471

The AP (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases Spike. ABC World News TonightVi (10/22, story 4, 3:00, Muir, 6.71M) r